The Role of Nanomedicine in Cell Based Therapeutics in Cancer and Inflammation

被引:1
作者
Samarasinghe, Rasika M. [1 ]
Kanwar, Rupinder K. [1 ]
Kanwar, Jagat R. [1 ]
机构
[1] Deakin Univ, Fac Hlth, Sch Med, NLIMBR, Geelong Tech Precinct GTP bldg, 75 Pigdons Rd, Geelong, Vic, Australia
关键词
Nanomedicine; cell therapy; cancer; blood brain barrier; inflammation;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Cell based therapeutics is one of the most rapidly advancing medical fields, bringing together a range of fields including transplantation, tissue engineering and regeneration, biomaterials and stem cell biology. However, traditional cell-based therapeutics have many limitations, one of which is their harmful effects exhibited on healthy body cells due to their lack of specificity. Nanomedicine is providing an alternative treatment strategy that is more targeted and specific to a range of diseases. Varying from polymers conjugated with drugs or tissue targeting molecules, to proteins encapsulated within a polymer shell, nanomedicine will without a doubt play a major role in designing effective cell-based therapeutics that can overcome certain classical problems. These may include from addressing the problem of non-specificity of contemporary treatments to overcoming mechanical barriers, such as crossing cell membranes. This review summarises the recent work on nano-based cell therapy as a regenerative agent and as a therapeutic for cancer and neurological diseases.
引用
收藏
页码:133 / 144
页数:12
相关论文
共 46 条
  • [1] Apoptosis-Inducing Effect of Garcinol Is Mediated by NF-κB Signaling in Breast Cancer Cells
    Ahmad, Aamir
    Wang, Zhiwei
    Ali, Raza
    Maitah, Ma'in Y.
    Kong, Dejuan
    Banerjee, Sanjeev
    Padhye, Subhash
    Sarkar, Fazlul H.
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2010, 109 (06) : 1134 - 1141
  • [2] Nanobiotechnologies in medicine: Nanodiagnostics and nanodrugs
    Archakov A.I.
    [J]. Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry, 2010, 4 (1) : 2 - 14
  • [3] Polymer micelles with cross-linked ionic cores for delivery of anticancer drugs
    Bontha, Satya
    Kabanov, Alexander V.
    Bronich, Tatiana K.
    [J]. JOURNAL OF CONTROLLED RELEASE, 2006, 114 (02) : 163 - 174
  • [4] Liposomes with tretinoin:: a physical and chemical evaluation
    Brisaert, M
    Gabriëls, M
    Matthijs, V
    Plaizier-Vercammen, J
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2001, 26 (5-6) : 909 - 917
  • [5] Choi HS, 2010, NAT NANOTECHNOL, V5, P42, DOI [10.1038/NNANO.2009.314, 10.1038/nnano.2009.314]
  • [6] Novel D-penicillamine carrying nanoparticles for metal chelation therapy in Alzheimer's and other CNS diseases
    Cui, ZR
    Lockman, PR
    Atwood, CS
    Hsu, CH
    Gupte, A
    Allen, DD
    Mumper, RJ
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2005, 59 (02) : 263 - 272
  • [7] Protamine enhances uptake of cationic liposomes in angiogenic microvessels of solid tumours
    Eichhorn M.E.
    Strieth S.
    Krasnici S.
    Sauer B.
    Teifel M.
    Michaelis U.
    Naujoks K.
    Dellian M.
    [J]. Angiogenesis, 2004, 7 (2) : 133 - 141
  • [8] Role of nanobiotechnology in cell-based nanomedicine: A concise review
    Emerich, Dwaine F.
    Halberstadt, Craig
    Thanos, Christopher
    [J]. JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2007, 3 (03) : 235 - 244
  • [9] Nanoparticles in cellular drug delivery
    Faraji, Amir H.
    Wipf, Peter
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (08) : 2950 - 2962
  • [10] Nano-interventions for neurodegenerative disorders
    Fernandes, Clara
    Soni, Umangi
    Patravale, Vandana
    [J]. PHARMACOLOGICAL RESEARCH, 2010, 62 (02) : 166 - 178